Blog Feed: Site provides developing information about prescription drug side effects as well as up-to-date news from the legal, me..
| Home | My Account | Directories |
Risk Of Femur Fractures From Osteoporosis Drugs Fosamax, Boniva, Actonel, And Reclast Related To Number Of Years Used
Published on 2012-05-22 15:11:00
Using These Bisphosphonates More Than Three (3) To Five (5) Years May Not Only Increase Side Effect Risk But There May Be No Benefit To Most Patients (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2012 there were medical journal articles in The New England Journal of Medicine (NEJM) and the Archives of Internal Medicine which, together, may cause millions of women to stop using the popular osteoporosis drugs Fosamax (or alendronate, its generic equivalent), Boniva, Actonel, and Reclast due t [..] > read more
Merck Funded Study Says There Is No Blood Clot Risk With NuvaRing, While BMJ Medical Journal Article Reports A 90% Increased Risk
Published on 2012-05-16 14:03:00
Perhaps These Conflicting Findings As Regards Serious NuvaRing Side Effects (PE, DVT, Stroke) Will Prompt FDA To Convene An Advisory Committee Meeting To Consider Safety Of This Vaginal Ring (Posted by Tom Lamb at DrugInjuryWatch.com) Some conflicting and rather disturbing data about the safety of Merck's NuvaRing vaginal ring birth control method emerged in early May 2012 from two different medical studies. The first study -- for which the costs were reimbursed by Merck, the marketer of NuvaRin [..] > read more
1,165 Fosamax - Femur Fracture Lawsuits Pending As Of December 31, 2011 According To Merck
Published on 2012-05-09 14:51:00
825 Lawsuits Are Part Of New Jersey State Court Mass Tort Consolidation; Majority Of Other Cases Are Filed In "Second" Fosamax Federal Court MDL (Posted by Tom Lamb at DrugInjuryWatch.com) The following information about the number of Fosamax - femur fracture lawsuits that had been filed before January 2012 comes from pages 117-118 of the Merck & Co., Inc. Form 10-K Annual Report For the Fiscal Year Ended December 31, 2011, which was filed with the Securities and Exchange Commission on February [..] > read more
The Victoza - Pancreatitis Issue: Some Related Developments From April 2011 To April 2012
Published on 2012-05-04 16:02:41
A Drug Safety Controversy Continues: Whether It Is The Diabetes Drug Or The Diabetes Which Causes Pancreas Disease (Posted by Tom Lamb at DrugInjuryWatch.com) As regards the possible association between Victoza and pancreatitis as a side effect of this diabetes drug from Novo Nordisk, there have quite a few assorted developments during the period April 2011 to April 2012. In order to get those all out in front of us, and so as to see how this drug safety issue emerged and where it may be headed [..] > read more
Bayer Settlements For YAZ / Yasmin Lawsuits Involving Blood Clot Side Effects Like Deep Vein Thrombosis And Pulmonary Embolism
Published on 2012-04-30 15:49:49
While Mediations And Negotiations Continue, The First Scheduled YAZ / Yasmin Trials In Federal And State Courts Are Postponed Indefinitely (Posted by Tom Lamb at DrugInjuryWatch.com) In late April 2012 Bayer announced that it has settled lawsuits involving YAZ and Yasmin side effects related to blood clots, namely deep vein thrombosis (DVT) and pulmonary embolism (PE) cases. From an April 26, 2012 Bloomberg news report, "Bayer Yasmin Lawsuit Settlements Climb to $142 Million": Bayer, based in Le [..] > read more
Pradaxa Noted For Possible Heart Attack Risk In Addition To Serious Gastrointestinal Bleeding And Other Hemorrhages
Published on 2012-04-24 15:04:00
Recent Medical Article And Poster Presentation Both Point To A Trend Toward Increased Rate Or Risk Of Myocardial Infarction (MI) (Posted by Tom Lamb at DrugInjuryWatch.com) A recent "position paper" by a group of experts from the European Society of Cardiology (ESC) Working Group on Thrombosis provides an update on the side effects associated with Pradaxa (dabigatran). In part, it pointed out there is increasing evidence of heart attacks, or myocardial infarction (MI), in patients using this rel [..] > read more
April 2012 Fosamax Trial Jury Verdict For Sessner v. Merck Case Expected Soon In New Jersey
Published on 2012-04-18 13:23:34
Closing Arguments Focus On Medical Issue Of Whether Or Not Fosamax Causes Osteonecrosis Of The Jaw (ONJ) (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Defense Verdict For Merck Ques #1: Did Mrs. Sessner have ONJ? Yes (6-0) Ques #2: Did Fosamax cause her ONJ? No (5-1) (4/18/12) ______________________________________________________________________________ On April 18, 2012 the jury for the Jo Ann Sessner vs. Merc [..] > read more
Pradaxa Hemorrhage Cases May Occur In Oldest Patients Due To Age-Related Decline In Renal Function
Published on 2012-04-16 14:04:00
QuarterWatch 2011 Quarter 2: More Pradaxa Adverse Events Reported Than Any Other Regularly Monitored Drug (Posted by Tom Lamb at DrugInjuryWatch.com) The developing emerging drug safety controversy involving the anticoagulation drug Pradaxa (dabigatran) has been presented best, perhaps, the ISMP QuarterWatch publicataion, which served as the basis for these two past articles about the problems with Pradaxa: (1) New Heart Drug Pradaxa May Be Sending "Early" Drug Safety Signals-- ISMP QuarterWatch [..] > read more
April 2012 Yasmin / YAZ Label Change: FDA Warns About Increased Risk Of Blood Clots Possible Due To Drospirenone
Published on 2012-04-10 15:15:27
Beyaz, Safyral, Ocella, Gianvi, Zarah, Loryna, Syeda, And Vestura OC Pills Contain DRSP Progestin Also (Posted by Tom Lamb at DrugInjuryWatch.com) On April 10, 2012 the FDA issued "Drug Information Update - Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone", an email alert which initially let us know about a significant revision to the package insert, or drug label, for the following oral contraceptive (OC) pi [..] > read more
Current Use Of Cipro And Levaquin Associated With Increased Risk Of Detached Retina Eye Injury
Published on 2012-04-04 16:10:00
Neither Recent Nor Past Use Of These Antibiotics In Fluoroquinolones Class Was Related To Retinal Detachment (Posted by Tom Lamb at DrugInjuryWatch.com) Patients taking oral antibiotics known as fluoroquinolones such as Cipro (ciprofloxacin) and Levaquin (levofloxacin) are at an increased risk for developing a detached retina, an eye injury which can lead to permanent blindness if not medically treated in a timely manner. This new drug safety finding comes from a case-control study, "Oral Fluoro [..] > read more
March 2012 Update: Generic Drug Manufacturers Immunity By Means Of Mensing Preemption Ruling
Published on 2012-03-29 14:10:00
One Year After The Hearing In Pliva v. Mensing, Some Momentum Builds For (Once Again) Allowing Drug Injury Lawsuits On All Prescription Medications, Generic As Well As Brand Name (Posted by Tom Lamb at DrugInjuryWatch.com) The Pliva, Inc., et al. v. Mensing case was decided by the Supreme Court of the United States (SCOTUS) on June 23, 2011. Justice Clarence Thomas delivered the opinion of the Court, concluding that federal drug regulations applicable to generic drug manufacturers directly confl [..] > read more
Pradaxa: 2012 Label Revisions In The U.S. And Canada, Where A "Dear Doctor" Letter Was Sent Out
Published on 2012-03-22 15:15:06
New Case Report About Routine Fall Involving An Elderly Patient That Results In Fatal Irreversible Brain Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran. Pradaxa is a blood-thinning drug used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. Since coming on the market in [..] > read more
950 NuvaRing Lawsuits Pending As Of December 31, 2011 According To Merck Annual Report
Published on 2012-03-15 13:40:00
820 Cases Are Filed In Federal Court NuvaRing MDL And 125 Lawsuits Are Part Of New Jersey State Court Mass Tort (Posted by Tom Lamb at DrugInjuryWatch.com) The following information about the number of NuvaRing lawsuits that had been filed before January 2012 comes from page 119 of the Merck & Co., Inc. Form 10-K Annual Report For the Fiscal Year Ended December 31, 2011, which was filed with the Securities and Exchange Commission on February 28, 2012: As of December 31, 2011, there were approxim [..] > read more
Fosamax - ONJ Litigation: Sessner v. Merck Trial In New Jersey State Court: Plaintiff's Opening Statement
Published on 2012-03-09 17:06:00
Jury Is Told Numerous Times By Her Attorney That Fosamax Did Nothing For Sessner, It Only Did Something To Her (Posted by Tom Lamb at DrugInjuryWatch.com) During his March 5, 2012 opening statement the plaintiff's attorney, Tim O'Brien, told members of the jury numerous times that Fosamax did nothing for Jo Ann Sessner, it only did something to her. It is alleged in this Fosamax lawsuit -- Jo Ann Sessner vs. Merck Sharp & Dohme Corp., ATL-L-3394-11 (MT), which is currently ongoing in a New Jerse [..] > read more
Current First NuvaRing Trial Date: New Jersey State Court Bellwether Case Set For Early February 2013
Published on 2012-03-08 16:16:00
Federal Court NuvaRing MDL Bellwether Trial Dates Pushed Back Several Times Previously; Perhaps It Will Be Late 2012 (Posted by Tom Lamb at DrugInjuryWatch.com) The first NuvaRing lawsuit has been scheduled to start trial in February 2013 pursuant to In Re: NuvaRing LitigationCase Management Order (CMO) # 19. New Jersey state court Judge Brian Martinotti, who is presiding over the NJ Mass Tort for NuvaRing cases stated: "It is anticipated by the Court that all nine (9) [of the selected "bellweth [..] > read more
Pradaxa Bleeding Events: Four Major Factors Which Contributed To These Serious Side Effects
Published on 2012-03-05 15:05:00
Prescriber Error, Impaired Renal Function, Patient Age, And Lack Of An Effective Reversal Agent Are Cited (Posted by Tom Lamb at DrugInjuryWatch.com) A Letter to The Editor, titled "Bleeding Risk with Dabigatran in the Frail Elderly" (subscription required), which appeared in the March 1, 2012 edition of the New England Journal of Medicine (NEJM) may help explain when and why there is a serious bleeding risk associated with Pradaxa (dabigatran). For those without access to the original March 201 [..] > read more
Yasmin / YAZ Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012
Published on 2012-02-28 15:11:27
Bayer 2011 Annual Report: Settlement Agreements: 70 Cases Settled As of Mid-February 2012; Negotiations Will Continue On Case-by-Case Basis (Posted by Tom Lamb at DrugInjuryWatch.com) From February 1, 2011 to February 1, 2012, the number of lawsuits pending in the United States served upon Bayer involving side effects allegedly from the use of Bayer’s oral contraceptive products Yasmin™ and/or YAZ™ or from the use of Ocella™ and/or Gianvi™ has increased from 6,850 (from the Bayer Annua [..] > read more
Fosamax Trial In New Jersey State Court Scheduled To Start Monday, February 27, 2012
Published on 2012-02-24 16:08:00
The Flores Case And The Sessner Case Involve Incidents Of ONJ Jaw Injury, Not The Femur Fracture Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) The trial for two Fosamax lawsuits -- Jo Ann Sessner vs. Merck Sharp & Dohme Corp., ATL-L-3394-11 (MT) and Amelia Flores vs. Merck Sharp & Dohme Corp.,ATL-L-744-09 (MT) -- is scheduled to start in the Superior Court of New Jersey, Atlantic County, on February 27, 2012. Judge Carol Higbee will be presiding over this NJ state court Fosamax trial. [..] > read more
Yasmin / Safyral / Beyaz: February 2012 Label Change: Non-Specific To These Bayer Birth Control Pills
Published on 2012-02-17 14:52:00
Same General Warning About All COCs Was Added To YAZ In March 2011; And Why The One Year Delay, We Wonder (Posted by Tom Lamb at DrugInjuryWatch.com) The February 14, 2012 email captioned "What's New on the FDA Drugs Site" let us know that there was a new version of the Package Insert for Yasmin, Safyral, and Beyaz which consisted of four new sentences being added to the WARNINGS AND PRECAUTIONS section: 5.1 Thromboembolic Disorders and Other Vascular Problems ... The risk of VTE in women using [..] > read more
Pradaxa: Excess Number Of Severe Bleeding Events In Certain Patient Populations And Settings
Published on 2012-02-10 12:38:00
At Increased Risk Are Patients Who Are Older, Have Altered Renal Clearance, Or Undergoing Atrial Fibrillation (AF) Ablation (Posted by Tom Lamb at DrugInjuryWatch.com) We first reported about Pradaxa (dabigatran) back in October 2011 in this article "New Heart Drug Pradaxa May Be Sending "Early" Drug Safety Signals". Our source back then and now, for this 2012 update, is the ISMP Quarterwatch publication, which monitors FDA MedWatch Reports for emerging drug safety issues. From the ISMP Quarterw [..] > read more
Gianvi Lawsuits Against The Drug Companies Still Possible After 2011 Supreme Court Preemption Ruling Re: Generic Drug Injury Lawsuits
Published on 2012-02-06 16:17:59
Reason Is That Bayer Has Been Supplying Teva And Barr With The Product For Their Gianvi Pills Since December 2010 (Agreement Is Similar To Ocella Deal) (Posted by Tom Lamb at DrugInjuryWatch.com) Gianvi, a generic version of YAZ, is marketed by Teva Pharmaceuticals and Barr Laboratories, which are commonly referred to as generic drug companies. Likewise, Ocella is a generic version of Yasmin that is sold by Teva and Barr. Unfortunately, most women who used the Gianvi birth control pills and suff [..] > read more
Pneumonia Trial Of Janssen / J&J Antibiotic Doribax Was Stopped In May 2011 -- We Learn From The FDA In January 2012
Published on 2012-01-30 16:06:00
"Significant Safety Concern": Higher Death Rate For Doribax In Ventilator-Associated Pneumonia When Compared To Patients Receiving Imipenem Therapy (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "Doribax (doripenem for injection) - Higher Mortality Rate and a Lower Clinical Cure Rate Observed During a Comparative Clinical Trial - Notice to Hospitals" [Health Canada, 1/31/12] The product monograph for Doribax will [..] > read more
YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More)
Published on 2012-01-23 14:11:00
11 Of The 26 FDA Panel Members Voted There Were No Sufficient Unique Benefits For YAZ / Yasmin That Cannot Be Found In Other Hormonal Contraceptives (Posted by Tom Lamb at DrugInjuryWatch.com) On December 8, 2011 the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting to discuss YAZ and Yasmin as well as several other relatively new birth control pills. In more detail, from the Summary Minutes of this YAZ / Yasmin December [..] > read more
Safety Profile Of New Stroke Drug Pradaxa Has Been Tarnished By Various Adverse Event Reports
Published on 2012-01-16 14:35:00
FDA Reviewing Serious Side Effects Associated With Pradaxa Ranging From Heart Attacks To Serious Bleeding or Hemorrhages (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Pradaxa label change: This January 17, 2012 FDA approval letter shows the revisions being made to current label. (1/19/12) ______________________________________________________________________________ Patients who use the new stroke drug Pradaxa ( [..] > read more
Prescription Drug Medication Errors Can Be Prevented By Taking Some Common Sense Precautions
Published on 2012-01-05 15:16:00
Ten Strategies Intended For Pharmacists Can Help Patients Stay Safe, Also (Posted by Tom Lamb at DrugInjuryWatch.com) It is relatively well-accepted in the healthcare community that medication errors involving prescription drugs happen more often than they should but the incident rate could be reduced if both pharmacists and patients took certain precautions. The following set of precautions, from the an article "Pharmacy Dispensing Mistakes: 10 Strategies for Minimizing Dispensing Errors" that [..] > read more
Fosamax Osteonecrosis Of The Jaw (ONJ) Federal Court MDL Litigation: A Mixed Forecast For 2012
Published on 2011-12-29 13:02:25
Three More Lawsuits (Boles, Jellema, and Spano) Set For Trial, And A Special Master Appointed To Conduct Settlement Talks (Posted by Tom Lamb at DrugInjuryWatch.com) There are currently more than 900 Fosamax lawsuits pending against defendant Merck Sharp & Dohme Corp. (“Merck”) in the federal court multidistrict litigation (MDL) concerning the osteonecrosis of the jaw (ONJ) and other jaw injury side effects. In the fourth quarter of 2011 United States District Court Judge Joseph F. Keenan, w [..] > read more
Women Who Use Bisphosphonates Like Fosamax And Boniva Have Increased Risk Of Femur Fracture / Thigh Bone Breaks
Published on 2011-12-22 16:52:00
December 2011: Some Recent Medical Studies About These Bisphosphonate-Related Subtorchanteric Or Atypical Femoral Fractures (Posted by Tom Lamb at DrugInjuryWatch.com) Here are some recent reports about medical studies concerning the association, or link, between bisphosphonate drugs such as Fosamax and Boniva that are used to treat osteoporosis and the risk of a rare but serious type of thigh bone fracture known as an "atypical femur fracture." (1) "Older women who use bisphosphonate for longer [..] > read more
Pradaxa: FDA Investigating Possible Higher Than Expected Incident Rate Of Serious Bleeding Side Effects
Published on 2011-12-15 13:15:28
Adverse Event Reports For This New Blood Thinner Drug May Exceed Pre-Approval Clinical Trial Observations (Posted by Tom Lamb at DrugInjuryWatch.com) In early December 2011 the FDA announced it is evaluating reports of bleeding in patients taking Pradaxa (dabigatran etexilate mesylate) that have been submitted to the agency's Adverse Events Reporting System (AERS) database to determine whether serious side effects are occurring at a higher rate than would be expected. Pradaxa is a relatively new [..] > read more
Actos And Avandia Use Associated With Diabetic Macular Edema, Which Can Lead To Blindness
Published on 2011-06-27 15:27:46
New UK Study Found Three To Six Times Increased Risk Of Developing This Retinal Eye Disease Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) A study presented at the American Diabetes Association’s annual meeting in San Diego on June 26, 201 > read more
Actos-Related Bladder Cancer: June 2011 Review Of Regulatory Actions And Safety Warnings
Published on 2011-06-17 16:37:00
FDA And Health Canada Warn About Increased Risk, While France And Germany Suspend Actos Sales (Posted by Tom Lamb at DrugInjuryWatch.com) We will start this Actos - bladder cancer safety review with the most recent announcement, from Health Canada ea > read more
June 2011 FDA Warning About 80 mg Dose Of Zocor, Simvastatin, And Vytorin Cholesterol Medications
Published on 2011-06-10 16:52:00
Highest Simvastatin Dosage Linked To Potentially Fatal Rhabdomyolysis Muscle Injury And Kidney Failure (Posted by Tom Lamb at DrugInjuryWatch.com) On June 8, 2011 the FDA announced dosing restrictions for pills containing 80 milligrams (mg) of simvas > read more
Acute Pancreatitis Case Associated With Victoza Use, Similar To Byetta And Januvia Case Reports
Published on 2011-06-06 15:30:00
Drug Safety Issue Controversy Continues: True Serious Side Effect, Or Attributable To Type 2 Diabetes Condition (Posted by Tom Lamb at DrugInjuryWatch.com) Novo Nordisk has a relatively new diabetes drug, Victoza (liraglutide), approved by FDA in 201 > read more
May 2011: Defense Verdict In Fourth Zometa Trial, Hogan v. Novartis
Published on 2011-05-27 12:24:00
Jury Considered Causation Issue And Label Warning About Osteonecrosis Of The Jaw (ONJ) (Posted by Tom Lamb at DrugInjuryWatch.com) In late May 2011 a federal court jury sitting in New York City found in favor of the drug company Novartis in a product > read more
Two New Books About Drug Injury Lawsuits, "All The Justice Money Can Buy" and "The Trial"
Published on 2011-05-23 16:45:00
First Covers One Of The Early Vioxx Cases, Second Is Legal Thriller Fiction With Parallels To Ketek Fiasco (Posted by Tom Lamb at DrugInjuryWatch.com) As the summer reading season draws near, we take a break from our usual reporting to let you know a > read more
Yasmin / YAZ MDL: First Trial Moved From September 2011 To January 2012 Per Plaintiffs' Request
Published on 2011-05-16 15:03:00
A Pulmonary Embolism Case Is Selected By Judge Herndon; More Than 6600 Lawsuits Filed Against Bayer As Of May 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2011 federal court Judge David R. Herndon announced that the first trial in MDL 2100 > read more
Fosamax: Femur Fractures And Osteonecrosis Of Jaw: Medical Journal Articles: May 2010 Update
Published on 2011-05-09 16:13:15
One Sees Mixed Findings About These Fosamax Side Effects From Various Research Reports And Case Studies (Posted by Tom Lamb at DrugInjuryWatch.com) Last month we wrote about the status of the thousands of Fosamax lawsuits that have been filed against > read more
Medical Journal Withdraws Article About Januvia And Byetta After It Gets Letters From Two Drug Companies
Published on 2011-05-02 15:12:00
April 2011 Edition Of BMJ Breaks News And Provides Insight From One Who Saw An Increased Risk Of Pancreatitis (Posted by Tom Lamb at DrugInjuryWatch.com) According to a news item published April 11, 2011 by The British Medical Journal (BMJ), letters > read more
Bayer Affirms Safety Of YAZ / Yasmin And Refutes 2011 BMJ Articles About Risk Of Blood Clots
Published on 2011-04-25 15:08:00
Just As It Did In 2010 Label Change, Bayer Contends New Medical Studies Are Less Reliable Than Other VTE Evidence (Posted by Tom Lamb at DrugInjuryWatch.com) Women who use Bayer's YAZ and Yasmin birth control pills -- or other oral contraceptives con > read more
Ortho Evra "Black-Box" Warning About Risks Of Blood Clots Added To Package Insert In March 2011
Published on 2011-04-18 14:40:00
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more c > read more
Reclast "Dear Doctor" Letter For Kidney Problems Should Be Sent By Novartis In U.S.
Published on 2011-04-11 14:04:00
Public Citizen March 2011 Letter To FDA Points To Aclasta Safety Alert Material Sent In Canada During October 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) To start, Reclast is the U.S. name for the zoledronic acid medication sold by Novartis; it > read more
Fosamax Litigation: Jaw Injury And Femur Fracture Cases, Federal And NJ Courts: April 2011 Update
Published on 2011-04-04 15:15:00
Secrest MDL Trial Moved From March to September 2011; Hester v. Merck ONJ Trial Set For May 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) The following information about the ongoing Fosamax litigation comes from pages 128-129 of the Merck & Co > read more
730 NuvaRing Lawsuits Filed As Of December 31, 2010 Per Merck Annual Report
Published on 2011-03-28 15:57:00
610 Cases Were In Federal Court NuvaRing MDL And 110 Complaints Filed In New Jersey State Court (Posted by Tom Lamb at DrugInjuryWatch.com) The following information about the number of NuvaRing lawsuits that had been filed before January 2011 comes > read more
Another Rather "Odd" YAZ Label Change By Bayer: March 2011
Published on 2011-03-21 16:04:00
Provides New Warnings About Certain Side Effects As Regards ALL Birth Control Pills (Not Specific To YAZ) (Posted by Tom Lamb at DrugInjuryWatch.com) The bottom line is this: There is nothing specific about YAZ in the new warning language added to th > read more
Generic Drug Company Should Not Be Allowed To Use Federal Preemption To Defeat Lawsuits
Published on 2011-03-14 13:12:00
U. S. Supreme Court Will Hear Oral Arguments On This Legal Issue In Drug Injury Lawsuit Involving Gladys Mensing (Posted by Tom Lamb at DrugInjuryWatch.com) On March 30, 2011 the U.S. Supreme Court will hear oral arguments in a drug injury case which > read more
Topamax During Pregnancy Increases Risk Of Cleft Lip And/Or Cleft Palate Birth Defects
Published on 2011-03-08 09:54:00
Oral Clefts In Babies Are 20 Times More Likely With Women Who Used Topamax (topiramate) After Getting Pregnant (Posted by Tom Lamb at DrugInjuryWatch.com) In early March 2011 the FDA announced that the prescribing information for Topamax and generic > read more
Zithromax Label Adds Warning About Drug-Induced Liver Injury In February 2011
Published on 2011-03-03 14:58:00
Adverse Reactions And Warnings Sections Now Include Hepatotoxicity, From Hepatic Dysfunction To Liver Failure (Posted by Tom Lamb at DrugInjuryWatch.com) The association between the antibiotic Zithromax (azithromycin) and drug-induced liver failure f > read more
Thigh Bone Leg Fractures In Older Women Using Fosamax, Boniva, And Reclast For Five Years Or More
Published on 2011-02-23 16:48:00
Long-Term Bisphosphonate Use Linked To Subtrochanteric And Femoral Shaft Fractures, Also Called Femur Fractures (Posted by Tom Lamb at DrugInjuryWatch.com) An article published in the February 23, 2011 edition of the medical journal JAMA (Journal of > read more
YAZ / Yasmin / Ocella Litigation: February 2011 Update
Published on 2011-02-16 14:41:48
The Number Of Birth Control Lawsuits Filed Against Bayer Now Exceeds 6000 (Posted by Tom Lamb at DrugInjuryWatch.com) The number of YAZ, Yasmin, and Ocella lawsuits filed on behalf of women who have developed a blood clot-related side effect, such as > read more
Fosamax MDL Judge Keenan Wants Two More Bellwether Case Trials: February 4, 2011 Order
Published on 2011-02-08 13:25:56
In Addition To The Federal Court Fosamax Jaw Injury Lawsuits Set For Trial In March 2011 And May 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) On February 4, 2011 Judge John F. Keenan, presiding over the federal court Fosamax multi-district litiga > read more
FDA Seeks Information About Topamax-Related Oral Cleft Birth Defect Cases
Published on 2011-02-01 16:00:00
Request For Historical Incidence Data Made In Connection With NDA For New Obesity Drug (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-January 2011 the biopharmaceutical company Vivus, Inc. -- while providing a regulatory update on its New Drug Ap > read more
First Fosamax Trial Against Merck In New Jersey State Court Starts In January 2011
Published on 2011-01-24 14:04:00
This Rosenberg v. Merck Case Involves Woman Who Alleges She Developed Osteonecrosis Of The Jaw (ONJ) (Posted by Tom Lamb at DrugInjuryWatch.com) On January 18, 2011 the first Fosamax trial involving bisphosphonate-related osteonecrosis of the jaw (ON > read more
Sanofi-Aventis "Dear Doctor" Letter Will Warn Heart Drug Multaq Associated With Liver Failure
Published on 2011-01-14 13:14:02
Liver Toxicity And Cardiac Side Effects Cause Dr. Steven Nissen To Express "concerns about the safety, efficacy and tolerability of dronedarone" (Posted by Tom Lamb at DrugInjuryWatch.com) On January 13, 2011 reporter Larry Husten posted on > read more
Psoriasis Drug Raptiva Alleged To Have Caused Hodgkin's Lymphoma Just Before April 2009 Recall
Published on 2011-01-13 15:55:00
2011 Raptiva Lawsuit Filed In Texas Against Drug Company: Failure To Warn About Side Effect Risks (Posted by Tom Lamb at DrugInjuryWatch.com) Back in 2009, we told you about some of the developments which led to Raptiva being withdrawn from the marke > read more
Fertility Drugs Clomid And Serophene Have Long Been Associated With Birth Defects
Published on 2011-01-07 07:45:00
Should These Drugs Have Stronger Warning About Increased Risk Of Fetal Abnormality After Clomiphene Use? (Posted by Tom Lamb at DrugInjuryWatch.com) Clomiphene is a prescription drug used for more than thirty years, now, to induce ovulation (egg prod > read more
Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis Are Serious Drug-Induced Skin Reactions
Published on 2010-12-30 13:30:09
SJS And TEN Differ In The Extent Of Skin Detachment, But Both Are Severe And Life-Threatening Drug Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) Stevens-Johnson syndrome (SJS) was first described in 1922, and toxic epidermal necrolysis (TE > read more
NuvaRing Update: First Trial Dates In MDL And New Jersey Mass Tort Litigation Not Until 2012, Now
Published on 2010-12-16 14:20:00
Discovery Deadlines And Expert Witness Deposition Dates Are Extended To Allow Time For Additional Document Review (Posted by Tom Lamb at DrugInjuryWatch.com) We learned in April 2010 from U.S. District Judge Rodney W. Sippel, who is presiding over th > read more
Prempro Litigation Report: Here Is A Tale of Two Very Different Recent Case Outcomes
Published on 2010-12-09 16:43:00
As Of December 2010 The Fourteen Jury Verdicts Are Evenly Split Between Defendant Pfizer And Plaintiffs (Posted by Tom Lamb at DrugInjuryWatch.com) We will start with the more recent case, Torkie-Tork v. Wyeth, 04-cv-945, U.S. District Court for the > read more
Use Of Avastin Or Sutent And I.V. Bisphosphonates May Increase Osteonecrosis Of Jaw (ONJ) Risk
Published on 2010-12-01 15:55:02
MHRA Warns UK Doctors To Monitor Cancer Patients For ONJ Where There Is Concomitant Use Of These Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) On November 30, 2010 the Medicines and Healthcare products Regulatory Agency (MHRA) issued two new safe > read more
First Levaquin Lawsuit Trial In Federal Court MDL Litigation Started In Mid-November 2010
Published on 2010-11-24 12:57:00
John Schedin v. Johnson and Johnson: Man Ruptured Achilles Tendons In Both Feet After Taking Levaquin (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________________ UPDATES: "J&J Los > read more